Denosumab for management of refractory hypercalcaemia in recurrent parathyroid carcinoma

European Journal of Endocrinology

Volumn 171, Issue 3, 2014, Pages L7-L8

  Nadarasa, K ^a   Theodoraki, A ^b   Kurzawinski, T R ^b   Carpenter, R ^a   Bull, J ^c   Chung, T T ^b   Drake, W M ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CINACALCET; DENOSUMAB; PARATHYROID HORMONE; MONOCLONAL ANTIBODY;

BONE METASTASIS; CALCIUM BLOOD LEVEL; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; ENDOCRINE SURGERY; EXTERNAL BEAM RADIOTHERAPY; FLUID RESUSCITATION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; JAW TUMOR; LETTER; LOW DRUG DOSE; LUNG METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; PARATHYROID CARCINOMA; SINGLE DRUG DOSE; BLOOD; MALE; NOTE; PARANEOPLASTIC SYNDROME; PARATHYROID TUMOR;

ANTIBODIES, MONOCLONAL, HUMANIZED; HUMANS; HYPERCALCEMIA; MALE; PARANEOPLASTIC SYNDROMES; PARATHYROID NEOPLASMS;

EID: 84907187459     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0482     Document Type: Letter

References (5)

1. Karuppiah D, Thanabalasingham G, Shine B, Wang LM, Sadler GP, Karavitaki N & Grossman AB. Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab. European Journal of Endocrinology 2014 171 K1-K5. (doi:10.1530/EJE-14-0166)
2. Wei CH & Harari A. Parathyroid carcinoma: update and guidelines for management. Current Treatment Options in Oncology 2012 13 11-23. (doi:10.1007/s11864-011-0171-3)
3. Ruggiero SL, Mehrotra B, Rosenberg TJ & Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. Journal of Oral and Maxillofacial Surgery 2004 62 527-534. (doi:10.1016/j.joms.2004.02.004)
4. Bowyer SE, White AM, Ransom DT & Davidson JA. Resistant hypercalcaemia in metastatic parathyroid carcinoma. Medical Journal of Australia 2013 198 559-561. (doi:10.5694/mja12.11243)
5. Vellanki P, Lange K, Elaraj D, Kopp PA & El Muayed M. Denosumab for management of parathyroid carcinoma-mediated hypercalcemia. Journal of Clinical Endocrinology and Metabolism 2014 99 387-390. (doi:10.1210/jc.2013-3031)